Ardelyx to Report Third Quarter 2025 Financial Results on October 30, 2025

Core Points - Ardelyx, Inc. will hold a conference call on October 30, 2025, at 4:30 p.m. Eastern Time to discuss third-quarter financial results and provide a business update [1] - The conference call will be accessible via phone and will also be webcasted live on the company's website, with a replay available for 30 days [2] Company Overview - Ardelyx is focused on discovering, developing, and commercializing innovative, first-in-class medicines to address significant unmet medical needs [3] - The company has two commercial products approved in the U.S.: IBSRELA (tenapanor) and XPHOZAH (tenapanor) [3] - Ardelyx has international agreements for the development and commercialization of tenapanor, including partnerships with Kyowa Kirin in Japan and Fosun Pharma in China [3]